Results 101 to 110 of about 2,722,809 (208)

Drug-resistant Tuberculosis [PDF]

Type: BacteriaAlso known as: TB, multidrug-resistant TB (MDR TB), or extensively drug-resistant TB (XDR TB), Mycobacterium tuberculosis (M. tuberculosis)About: TB is caused by the bacteria M. tuberculosis, and is among the most common infectious diseases

core  

Drug-resistant tuberculosis: emerging treatment options

, 2011
Meghna Adhvaryu1, Bhasker Vakharia21Department of Biotechnology, SRK Institute of Computer Education and Applied Sciences, 2R&D, Bhuma Research in Ayurvedic and Herbal Medicine, Surat, Gujarat, IndiaAbstract: Multidrug-resistant tuberculosis has ...
Vakharia BC, Adhvaryu MR
core  

Association of bacteriomes with drug susceptibility in lesions of pulmonary tuberculosis patients

Heliyon
Understanding how the bacteriomes in tuberculous lesions can be influenced by the susceptibility of Mycobacterium tuberculosis (MTB) can provide valuable information for preventing and treating drug resistant tuberculosis (DR-TB).
Weili Du, Yingli Zhao, Chen Zhang, Li Zhang, Lijuan Zhou, Zuyu Sun, Xiaojie Huang, Nana Zhang, Zichen Liu, Kun Li, Nanying Che   +10 more
doaj   +1 more source

The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data

Journal of Infection and Public Health
Background: Drug-resistant tuberculosis (TB), especially multidrug-resistant tuberculosis (MDR-TB), constitutes a major obstacle to fulfill end TB strategy globally.
Shanshan Li, Yaoju Tan, Yufeng Deng, Guanghong Bai, Mingxiang Huang, Yuanyuan Shang, Yufeng Wang, Zhongtan Xue, Xuxia Zhang, Wei Wang, Junhua Pan, Yu Pang   +11 more
doaj   +1 more source

A Prospective Assessment of Therapeutic Efficacy and Immune Effects of Levofloxacin and Ofloxacin in Multiple-Drug Resistant Tuberculosis

, 2010
Background: Multi-drug resistant tuberculosis impairing the effectiveness of standard treatments may contribute to increased mortality. High failure and relapse rates are recorded when standard regimens are used for multi-drug resistant tuberculosis ...

core  

Innowave MTB/RIF/INH facilitates timely and accurate diagnosis of multiple-drug resistant tuberculosis as a near POCT technique: a multicenter prospective on-site performance evaluation study

Annals of Clinical Microbiology and Antimicrobials
Background Many rifampicin (RIF)-resistant (RR) tuberculosis (TB) patients remain sensitive to isoniazid (INH), which challenges the strategy of using RR as an instant indicator of multiple-drug resistance tuberculosis (MDR-TB).
Fen Wang, Long Cai, Zhongfeng Cui, Guanglu Jiang, Hairong Huang   +4 more
doaj   +1 more source

Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture.

, 2010
Acquisition of antibiotic resistance in Mycobacterium tuberculosis has been shown to incur a fitness cost; the size of which depends on the position and nature of the mutation. The frequency at which resistant M. tuberculosis strains are isolated in vivo
Gillespie, S. H., O'Sullivan, DM, T. D. McHugh, McHugh, TD, S. H. Gillespie, Gillespie, SH, O'Sullivan, D. M., McHugh, T. D., D. M. O'Sullivan   +8 more
core   +1 more source

Flexibility and innovation in response to emerging infectious diseases: Reactions to multi-drug resistant Tuberculosis in India [PDF]

Emerging infectious diseases regained substantial international attention in recent years and it has been argued that flexibility and innovation in public health systems is needed in order to react to changing challenges.
Engel, Nora
core  

Extensively drug-resistant tuberculosis: epidemiology and management

, 2014
Alberto Matteelli,1 Alberto Roggi,1 Anna CC Carvalho21Institute of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-Infection, University of Brescia, Brescia, Italy; 2Laboratory of Innovations in Therapies, Education and ...
Roggi A, Carvalho ACC, Matteelli A
core  

Europe's failure to deliver on drug-resistant tuberculosis. [PDF]

Lancet Reg Health Eur
The Lancet Regional Health-Europe.
europepmc   +1 more source